AtriCure (ATRC) Other Non-Current Assets (2010 - 2026)
AtriCure (ATRC) posted quarterly Other Non-Current Assets of $4.6 million for Q2 2026, up 63.76% year-over-year from $2.8 million in Q2 2025, and up 24.27% quarter-over-quarter from $3.7 million in Q1 2026.
AtriCure (ATRC) Other Non-Current Assets (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Other Non-Current Assets for 17 consecutive years, with $4.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 63.76% year-over-year to $4.6 million; the TTM figure through Jun 2026 stood at $4.6 million (up 63.76% YoY), while the FY2025 annual figure was $2.9 million, changed 0.14% from the prior year.
- Other Non-Current Assets advanced to $4.6 million in Q2 2026 per ATRC's latest filing, from $3.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.6 million in Q2 2026 and bottomed at $685000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $2.4 million across 5 years, with a median of $2.8 million in 2025.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets fell 21.42% — and 2023, when it jumped 136.5%.
- AtriCure's Other Non-Current Assets stood at $2.0 million in 2022, then gained by 8.82% to $2.2 million in 2023, then surged by 32.78% to $2.9 million in 2024, then decreased by 0.14% to $2.9 million in 2025, then surged by 59.99% to $4.6 million in 2026.
- Business Quant data shows ATRC's Other Non-Current Assets at $4.6 million in Q2 2026, $3.7 million in Q1 2026, and $2.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 4.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.58 Mn |
| Mar 31, 2026 | 3.69 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 804,000.00 |
| Mar 31, 2022 | 685,000.00 |
| Dec 31, 2021 | 955,000.00 |
| Sep 30, 2021 | 1.06 Mn |